Stephen Gucker

Array ( [id] => 6536169 [patent_doc_number] => 20020193301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'TGF-alpha polypeptides, functional fragments and methods of use therefor' [patent_app_type] => new [patent_app_number] => 10/039119 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22961 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193301.pdf [firstpage_image] =>[orig_patent_app_number] => 10039119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788300 [patent_doc_number] => 20020160941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Treating compositions with lactoferrin' [patent_app_type] => new [patent_app_number] => 10/023096 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9332 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160941.pdf [firstpage_image] =>[orig_patent_app_number] => 10023096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668912 [patent_doc_number] => 20030113896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Purified antigen for Alzheimer\'s disease and methods of obtaining and using same' [patent_app_type] => new [patent_app_number] => 10/017822 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14550 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113896.pdf [firstpage_image] =>[orig_patent_app_number] => 10017822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1082739 [patent_doc_number] => 06833237 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-21 [patent_title] => 'Genes involved in stroke response and/or regulated by FK506, proteins encoded thereby, and methods of use' [patent_app_type] => B1 [patent_app_number] => 10/021338 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 39300 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833237.pdf [firstpage_image] =>[orig_patent_app_number] => 10021338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774141 [patent_doc_number] => 20030017479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Methods for the detection, treatment, and prevention of neurodegeneration' [patent_app_type] => new [patent_app_number] => 10/014079 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10048 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017479.pdf [firstpage_image] =>[orig_patent_app_number] => 10014079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 190917 [patent_doc_number] => 07642228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Method for making heteromultimeric polypeptides' [patent_app_type] => utility [patent_app_number] => 10/010245 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 21742 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642228.pdf [firstpage_image] =>[orig_patent_app_number] => 10010245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1098391 [patent_doc_number] => 06818215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => 'Antibodies to senescent cell-derived inhibiters of DNA synthesis' [patent_app_type] => B2 [patent_app_number] => 10/008960 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 50461 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818215.pdf [firstpage_image] =>[orig_patent_app_number] => 10008960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6687929 [patent_doc_number] => 20030031654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Prohormone convertase transformed cells and polypeptide synthesis' [patent_app_type] => new [patent_app_number] => 09/997868 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31181 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031654.pdf [firstpage_image] =>[orig_patent_app_number] => 09997868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 727976 [patent_doc_number] => 07041457 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors' [patent_app_type] => utility [patent_app_number] => 09/989497 [patent_app_country] => US [patent_app_date] => 2001-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5037 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041457.pdf [firstpage_image] =>[orig_patent_app_number] => 09989497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361065 [patent_doc_number] => 20020058613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Methods of controlling axonal growth' [patent_app_type] => new [patent_app_number] => 10/035376 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15025 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058613.pdf [firstpage_image] =>[orig_patent_app_number] => 10035376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6438611 [patent_doc_number] => 20020128186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Antimicrobial polypeptide, nucleic acid, and methods of use' [patent_app_type] => new [patent_app_number] => 10/013036 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8861 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128186.pdf [firstpage_image] =>[orig_patent_app_number] => 10013036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999783 [patent_doc_number] => 20020028473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid' [patent_app_type] => new [patent_app_number] => 09/984304 [patent_app_country] => US [patent_app_date] => 2001-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7976 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028473.pdf [firstpage_image] =>[orig_patent_app_number] => 09984304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736015 [patent_doc_number] => 20030013650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'VR-OAC, an osomotically activated channel protein, nucleic acids encoding it, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/027828 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 39531 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013650.pdf [firstpage_image] =>[orig_patent_app_number] => 10027828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668917 [patent_doc_number] => 20030113901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Cell production' [patent_app_type] => new [patent_app_number] => 10/045963 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3228 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113901.pdf [firstpage_image] =>[orig_patent_app_number] => 10045963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613161 [patent_doc_number] => 20100310452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 10/012169 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 103 [patent_no_of_words] => 30308 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310452.pdf [firstpage_image] =>[orig_patent_app_number] => 10012169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 773282 [patent_doc_number] => 07001763 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Human semaphorin proteins and polynucleotides encoding the same' [patent_app_type] => utility [patent_app_number] => 09/981318 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9307 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001763.pdf [firstpage_image] =>[orig_patent_app_number] => 09981318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1334836 [patent_doc_number] => 06596852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Antibodies that bind the cytokine designated LERK-5' [patent_app_type] => B2 [patent_app_number] => 09/978339 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13143 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596852.pdf [firstpage_image] =>[orig_patent_app_number] => 09978339 [rel_patent_id] =>[rel_patent_doc_number] =>)